rbx2660
Showing 1 - 4 of 4
Clostridium Difficile Infection Recurrence Trial in North Little Rock, Shreveport (RBX2660)
Recruiting
- Clostridium Difficile Infection Recurrence
- RBX2660
-
North Little Rock, Arkansas
- +1 more
Apr 27, 2023
Clostridium Difficile Infection, Infection, Communicable Diseases Trial in Canada, United States (RBX2660)
Active, not recruiting
- Clostridium Difficile Infection
- +2 more
- RBX2660
-
Phoenix, Arizona
- +50 more
Jan 11, 2023
Clostridium Difficile Infection Trial in Canada, United States (RBX2660, Placebo)
Completed
- Clostridium Difficile Infection
- RBX2660
- Placebo
-
Athens, Alabama
- +65 more
Jul 29, 2022
Clostridium Difficile Infection Trial in Canada, United States (RBX2660, Standard of Care Antibiotics)
Completed
- Clostridium Difficile Infection
- RBX2660
- Standard of Care Antibiotics
-
Phoenix, Arizona
- +29 more
Mar 25, 2021